Eisler Capital Management Ltd. Abb Vie Inc. Call Options Transaction History

Eisler Capital Management Ltd.

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2025 Nov 13, 2025	SELL	$184.85 - $231.54 $1.66 Million - $2.08 Million	-9,000 Reduced 5.29%	161,100 $37.3 Million
Q2 2025 Aug 12, 2025	BUY	$170.16 - $206.27 $1.96 Million - $2.37 Million	11,500 Added 7.25%	170,100 $31.6 Million
Q1 2025 May 14, 2025	BUY	$169.2 - $216.66 $1.71 Million - $2.19 Million	10,100 Added 6.8%	158,600 $33.2 Million
Q4 2024 Feb 14, 2025	BUY	$164.99 - $203.87 $24.5 Million - $30.3 Million	148,500 New	148,500 $26.4 Million

4,491

1.28B

16.9M

15.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $414B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Eisler Capital Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital Management Ltd. with notifications on news.